Evaluación y opciones de tratamiento en pacientes con falla posterior a la prostatectomía por cáncer localizado de la próstata

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Revista Mexicana de Urología

• Publication date

  2011-03-01

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Editorial comment.

  2013cited by this paper
• Natural history of biochemical progression after radical prostatectomy based on length of a positive margin.

  2008cited by this paper
• Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.

  2008cited by this paper
• Phase III Results of Adjuvant Radiotherapy Versus “Wait and See” in Patients With pT3 Prostate Cancer Following Radical Prostatectomy (ARO 96-02/AUO AP 09/95)

  2007cited by this paper
• Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer: A Randomized Clinical Trial

  2007cited by this paper
• 11C-acetate PET imaging in prostate cancer

  2007cited by this paper
• Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins.

  2006cited by this paper
• Postoperative Radiotherapy After Radical Prostatectomy: A Randomized Controlled Trial (EORTC trial 22911)

  2006cited by this paper
• The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer.

  2006cited by this paper
• Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.

  2006cited by this paper
• Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer

  2006cited by this paper
• Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

  2005cited by this paper
• Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time

  2005cited by this paper
• Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.

  2004cited by this paper
• Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy.

  2004cited by this paper
• 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial.

  2004cited by this paper
• The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy.

  2004cited by this paper
• 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.

  2003cited by this paper
• Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy.

  2003cited by this paper
• Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

  2003cited by this paper
• Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate.

  2001cited by this paper
• Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin.

  2000cited by this paper
• Follow‐up ProstaScint® scans verify detection of occult soft‐tissue recurrence after failure of primary prostate cancer therapy

  2000cited by this paper
• Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis.

  1999cited by this paper
• Comparison of outcomes of radical prostatectomy with and without adjuvant pelvic irradiation in patients with pathologic stage C (T3N0) adenocarcinoma of the prostate.

  1999cited by this paper
• Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer.

  1999cited by this paper
• Natural history of progression after PSA elevation following radical prostatectomy.

  1999cited by this paper
• Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel.

  1999cited by this paper
• Is there a role for digital rectal examination in the followup of patients after radical prostatectomy?

  1999cited by this paper
• Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer.

  1999cited by this paper
• How to explore the patient with a rising PSA after radical prostatectomy: defining local versus systemic failure.

  1999cited by this paper
• Correlation of margin status and extraprostatic extension with progression of prostate carcinoma

  1999cited by this paper
• Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy.

  1999cited by this paper
• Factors predicting cancer detection in biopsy of the prostatic fossa after radical prostatectomy.

  1998cited by this paper
• Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma

  1998cited by this paper
• Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.

  1998cited by this paper
• Use of second treatment following definitive local therapy for prostate cancer: data from the caPSURE database.

  1998cited by this paper
• Therapeutic radiation in patients with a rising post-prostatectomy PSA level.

  1998cited by this paper
• Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer

  1998cited by this paper
• Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose.

  1998cited by this paper
• Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy.

  1998cited by this paper
• Evaluation and management of men whose radical prostatectomies failed: results of an international survey.

  1998cited by this paper
• Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer.

  1998cited by this paper
• Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results.

  1998cited by this paper
• Radiation therapy after prostatectomy: now or later?

  1998cited by this paper
• Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy.

  1997cited by this paper
• Androgen deprivation and radiation therapy: sequencing studies using the Shionogi in vivo tumor system.

  1997cited by this paper
• Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer.

  1997cited by this paper
• Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level.

  1997cited by this paper
• Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation.

  1997cited by this paper
• Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.

  1997cited by this paper
• Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen.

  1997cited by this paper
• Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy. A long term follow-up.

  1996cited by this paper
• Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up.

  1996cited by this paper
• Risk factors for progression in patients with prostate cancer treated with radical prostatectomy.

  1996cited by this paper
• Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.

  1996cited by this paper
• Variable histology of anastomotic biopsies with detectable prostate specific antigen after radical prostatectomy.

  1995cited by this paper
• Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group.

  1995cited by this paper
• Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update.

  1995cited by this paper
• Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases.

  1994cited by this paper
• Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer.

  1994cited by this paper
• Impact of radical prostatectomy in the management of clinically localized disease.

  1994cited by this paper
• Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment.

  1994cited by this paper
• Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy.

  1993cited by this paper
• Correlation of pathologic findings with progression after radical retropubic prostatectomy

  1993cited by this paper
• The Mechanisms and Prognostic Significance of Seminal Vesicle Involvement by Prostate Cancer

  1993cited by this paper
• Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.

  1993cited by this paper
• Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.

  1993cited by this paper
• Positive surgical margins at radical prostatectomy: importance of the apical dissection.

  1990cited by this paper
• Nerve-sparing radical prostatectomy: evaluation of results after 250 patients.

  1990cited by this paper
• Prostate specific antigen and local recurrence after radical prostatectomy.

  1990cited by this paper
• Radiation therapy as adjuvant treatment after radical prostatectomy.

  1988cited by this paper
• Postoperative radiation therapy for pathologic stage C prostate cancer.

  1987cited by this paper
• Postoperative irradiation in carcinoma of the prostate.

  1984cited by this paper

• Clinical Variables in the Diagnosis and Treatment of Advanced Hormone Sensitive Prostate Cancer

  2023cites this paper